Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 31;11(4):1062.
doi: 10.3390/biomedicines11041062.

The Role of Ablative Techniques in the Management of Hepatocellular Carcinoma: Indications and Outcomes

Affiliations
Review

The Role of Ablative Techniques in the Management of Hepatocellular Carcinoma: Indications and Outcomes

Asanda Koza et al. Biomedicines. .

Abstract

The management of hepatocellular carcinoma (HCC) remains complex and will continue to rely on the multidisciplinary input of hepatologists, surgeons, radiologists, oncologists and radiotherapists. With the appropriate staging of patients and selection of suitable treatments, the outcomes for HCC are improving. Surgical treatments encompassing both liver resection and orthotopic liver transplantation (OLT) are the definitive curative-intent options. However, patient suitability, as well as organ availability, pose essential limitations. Consequently, non-surgical options, such as ablative techniques, play an increasingly important role, especially in small HCCs, where overall and disease-free survival can be comparable to surgical resection. Ablative techniques are globally recommended in recognised classification systems, showing increasingly promising results. Recent technical refinements, as well as the emerging use of robotic assistance, may expand the treatment paradigm to achieve improved oncological results. At present, in very early stage and early stage unresectable disease, percutaneous thermal ablation is considered the treatment of choice. Owing to their different features, various ablative techniques, including radiofrequency ablation, microwave ablation, cryotherapy ablation and irreversible electroporation, have been shown to confer different comparative advantages and applicability. We herein review the role of available ablative techniques in the current complex multidisciplinary management of HCC, with a main focus on the indications and outcomes, and discuss future perspectives.

Keywords: Hepatocellular carcinoma; ablative techniques; cryotherapy; interventional radiology; irreversible electroporation; microwave ablation; radiofrequency ablation.

PubMed Disclaimer

Conflict of interest statement

N.F. reports consultancy from Ethicon—Johnson & Johnson, and Boston Scientific; lecture fees from Ethicon—Johnson & Johnson. The remaining authors have no conflict of interest to declare.

Figures

Figure 1
Figure 1
Radiofrequency ablation (RFA) probe with expandable system.
Figure 2
Figure 2
(a) Planning CT for microwave ablation of solitary hepatocellular carcinoma (Archive of Dr Fotiadis, The Royal Marsden Hospital). (b) Microwave ablation of solitary hepatocellular carcinoma (Archive of Dr Fotiadis, The Royal Marsden Hospital). (c) Post-ablation CT (Archive of Dr Fotiadis, The Royal Marsden Hospital).

References

    1. Kawaguchi Y., Honda G., Endo I., Cherqui D., Kokudo N. Current Technical Issues for Surgery of Primary Liver Cancer. Liver Cancer. 2016;6:51–58. doi: 10.1159/000449345. - DOI - PMC - PubMed
    1. Daher S., Massarwa M., Benson A.A., Khoury T. Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review. J. Clin. Transl. Hepatol. 2018;6:69–78. doi: 10.14218/JCTH.2017.00031. - DOI - PMC - PubMed
    1. Minami Y., Kudo M. Radiofrequency ablation of hepatocellular carcinoma: Current status. World J. Radiol. 2010;2:417–424. doi: 10.4329/wjr.v2.i11.417. - DOI - PMC - PubMed
    1. Reig M., Forner A., Rimola J., Ferrer-Fàbrega J., Burrel M., Garcia-Criado Á., Kelley R.K., Galle P.R., Mazzaferro V., Salem R., et al. BCLC strategy for prognosis prediction and treatment recommendation Barcelona Clinic Liver Cancer (BCLC) staging system: The 2022 update. J. Hepatol. 2022;76:681–693. doi: 10.1016/j.jhep.2021.11.018. - DOI - PMC - PubMed
    1. Huang D.Q., El-Serag H.B., Loomba R. Global epidemiology of NAFLD-related HCC: Trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 2020;18:223–238. doi: 10.1038/s41575-020-00381-6. - DOI - PMC - PubMed

LinkOut - more resources